key: cord-0808934-1plvah4z authors: Kim, Hyung-Jun; Hwang, Hyeontaek; Hong, Hyunsook; Yim, Jae-Joon; Lee, Jinwoo title: A systematic review and meta-analysis of regional risk factors for critical outcomes of COVID-19 during early phase of the pandemic date: 2021-05-07 journal: Sci Rep DOI: 10.1038/s41598-021-89182-8 sha: 6909587f56dce216c243c62d61a59f955e5c64ea doc_id: 808934 cord_uid: 1plvah4z The mortality rates of COVID-19 vary across the globe. While some risk factors for poor prognosis of the disease are known, regional differences are suspected. We reviewed the risk factors for critical outcomes of COVID-19 according to the location of the infected patients, from various literature databases from January 1 through June 8, 2020. Candidate variables to predict the outcome included patient demographics, underlying medical conditions, symptoms, and laboratory findings. The risk factors in the overall population included sex, age, and all inspected underlying medical conditions. Symptoms of dyspnea, anorexia, dizziness, fatigue, and certain laboratory findings were also indicators of the critical outcome. Underlying respiratory disease was associated higher risk of the critical outcome in studies from Asia and Europe, but not North America. Underlying hepatic disease was associated with a higher risk of the critical outcome from Europe, but not from Asia and North America. Symptoms of vomiting, anorexia, dizziness, and fatigue were significantly associated with the critical outcome in studies from Asia, but not from Europe and North America. Hemoglobin and platelet count affected patients differently in Asia compared to those in Europe and North America. Such regional discrepancies should be considered when treating patients with COVID-19. The 80 studies included 43,248 patients, with a median of 130 patients per study (interquartile range . The studies were conducted in Asia (n = 48), Europe (n = 22), and North America (n = 10). The countries included China (n = 43), the United States of America (n = 10), Italy (n = 9), Spain (n = 5), Iran (n = 3), the United Kingdom (n = 3), South Korea (n = 1), India (n = 1), Denmark (n = 1), France (n = 1), Greece (n = 1), Norway (n = 1), and Poland (n = 1). The study outcomes were death (n = 41, 51.3%), admission to the ICU (n = 15, 18.8%), admission to the ICU or death (n = 9, 11.3%), and critical type of COVID-19 (n = 15, 18.8%). A median of 23.7% of patients had suffered the critical outcome in the overall population and was highest in studies from North America (34.8%), followed by Europe (26.5%) and Asia (17.3%) (P < 0.001). Most of the studies were retrospective observational studies (n = 68, 85.0%). Of the 80 studies, 50 (62.5%) did not specify any restriction in patient selection, while 13 studies included patients with certain comorbidities, seven with certain COVID-19 severity, and four with computed tomography findings (Table 1) Fig. S4 ). Publication biases were not observed in these analyses (Egger's P = 0.388, 0.282, and 0.557, respectively). While most studies at least partly met the quality standards of each area, several studies did not. The two studies did not represent the population of interest (study participation), two studies did not adequately measure the prognostic factor of interest (prognostic factor measurement), and nine studies did not account for important potential confounders (confounding measurement and account). (Supplementary Table S2 ). Most of the variables did not show any publication bias; however, male sex (P = 0.042), underlying diabetes (P = 0.001), malignancy (P = 0.020), cerebral disease (P = 0.042), symptoms of dyspnea (P = 0.019), and vomiting (P = 0.045) revealed significant publication bias. Laboratory findings of lymphocyte count (P = 0.003), ALT (P = 0.012), and AST (P = 0.023) also revealed publication biases (Supplementary Table S3 ). selection, outcome confined to death, and at least partly achieving every standard of the six areas of potential study biases. The results were largely consistent with the main analyses. Male sex (pooled RR 1. 17 www.nature.com/scientificreports/ 0.14], I 2 = 63.0%, 7 studies). The results of the sensitivity analysis are summarized in Supplementary Fig. S5 , and the details are described in Supplementary Table S4 . This is the first study to summarize the risk factors for the critical outcomes (death, admission to the ICU, or critical type of COVID-19) of COVID-19 according to the location of infected patients. It is also the largest updated systematic review regarding risk factors for the poor prognosis of patients with COVID-19. While most risk factors were largely similar across the three continents, several differences were noted. The presence of respiratory disease was associated with a higher risk of the critical outcome in Asia and Europe, but not North America. The presence of hepatic disease was associated with a higher risk of the critical outcome in Europe, but not in Asia and North America. Symptoms of vomiting, anorexia, dizziness, and fatigue were significantly associated with the critical outcome in Asia, but not Europe and North America. While platelet count was inversely associated www.nature.com/scientificreports/ with the critical outcome in Asia, it was not in Europe and North America. In contrast, lower hemoglobin levels were associated with the poor outcome in Europe but not in Asia and North America. Our findings of the overall population are consistent with those of previous reviews. Male sex, older age, underlying comorbidities, and several laboratory parameters have been repeatedly emphasized as risk factors for poor outcomes in patients with COVID-19 9, 10, [99] [100] [101] [102] [103] . This disease is well-known for male-sex predominant deterioration. A nationwide study from Denmark reported that male sex was an independent risk factor for death even after adjusting for age and comorbidities 104 . The underlying mechanism for this observation has not yet been elucidated but may be explained by the immune regulatory genes encoded by the X chromosome, which makes men more susceptible to viral infections as compared to women 105 . In addition, sex hormones may act directly in innate immune cells to regulate their function, and indirectly via non-immune cells resulting in immune cell actions 106 . Older age was also a risk factor for grave prognosis among COVID-19 patients in previous systematic reviews 9, 10 . This is easily understandable as old age is also a well-known risk factor for death among patients with community-acquired pneumonia and influenza [107] [108] [109] . Among many symptoms, dyspnea was the only symptom that was consistently associated with a higher risk of the critical outcome in all three continents, a finding concordant with those in previous reviews 9, 102 . Dyspnea is relatively uncommon among COVID-19 patients despite typical lung involvement 2, 110 . Therefore, the presence of dyspnea could imply extensive involvement of the lung and lead to poor outcomes. The results of our study not only confirm previous knowledge regarding the risk factors for the deterioration of COVID-19 patients but also reveal some novel findings. First, some risk factors revealed inter-continental differences. Recognizing such differences can aid the development of proper guidelines for the management of patients according to their region and ethnicity. As noted, underlying respiratory disease was associated with the critical outcomes in Asia and Europe, but not in North America. Although the exact reason for this disparity is beyond the scope of our review, it may be partly explained by the differences in therapies for the treatment of these chronic respiratory diseases 111 . In China, only about 56% of patients with chronic obstructive pulmonary disease receive treatments that are standard in Western countries, while 23% receive Chinese traditional treatments 111 . Considering the protective effect of corticosteroids in the treatment of COVID-19 112 , such a gap in the treatment of chronic respiratory disease may have led to different outcomes among continents. Underlying hepatic disease also showed different impacts on critical outcomes across the three continents. This may be partly due to differences in per capita alcohol consumption, which is higher in Europe compared to North America and Asia 113 . Alcohol consumption is also associated with mortality rates among patients with liver cirrhosis 114 and also increases the severity of respiratory viral infection and pneumonia 115, 116 . Thus, patients from Europe with hepatic disease may have had worse prognoses compared to those in patients from North America and Asia. Among the symptoms of COVID-19, vomiting, anorexia, dizziness, and fatigue were risk factors in Asia, but not in Europe and North America. These symptoms can be associated with weight loss and poor nutritional status during the course of the disease, while BMI is mostly higher for individuals living in Europe and North America, compared to those in Eastern Asian countries 117 . Although our meta-analysis suggested that Hispanic patients may have better prognosis compared to non-Hispanic white, the impact of ethnicity on the prognosis of COVID-19 is yet to be explained. While a regional study from the United States reported that ethnicity may be a factor for diverse outcomes 118 , other studies denied these findings after adjusting for risk factors 119, 120 . A recent meta-analysis of has suggested that, after adjusting patient characteristics, ethnicity may not be an independent prognostic factor 121 . Second, with enough pooled analysis, various comorbidities are proven to be risk factors. Because viral infections can cause a systemic inflammatory response which can induce myocardial injury and vascular inflammation 122, 123 , studies have focused on diseases associated with cardiovascular outcomes as risk factors. In previous systematic reviews including 13, 16, 25 , and 36 studies 9,99,101,124 , underlying cardiovascular disease, hypertension, diabetes, congestive heart failure, cerebrovascular disease, chronic kidney disease, respiratory disease, and cancer were identified as risk factors for poor patient outcome. The reviews did not find or mention any significant impact of underlying liver disease. However, several studies have inferred the impact of liver disease on the prognosis of COVID-19. For example, laboratory abnormalities associated with hepatic dysfunction were frequently observed in patients with COVID-19, and were more common in severe forms of COVID-19 125 . Furthermore, a pooled analysis showed a higher incidence of acute hepatic injury in severe COVID-19 compared to that in non-severe disease 126 . To correctly acknowledge our study findings, several limitations should be noted. First, most of the included studies had retrospective design. This was inevitable because COVID-19 is a novel disease that caused a sudden pandemic. Second, residual heterogeneity was observed in the analyses of continuous variables. The residual extent of heterogeneity may be partially explained by differences in the reported forms of the variables (i.e., mean and SD, median and range, median, and interquartile range), age distribution, level of care, medication details, and nutritional status among studies. Third, some key factors, such as pregnancy, could not be evaluated because they were not commonly reported 127 . Our extensive systematic review summarized the risk factors associated with the critical outcome (death, admission to the ICU, and critical type of COVID-19) of COVID-19 patients according to location of infected patients (Asia, Europe, and North America). Although the risk factors were mostly consistent across the three continents, underlying diseases, patient symptoms, and laboratory findings posed different impact on patient prognosis in each location. Future studies are required to understand the reasons for such discrepancy. The data used in this systematic review is available from the corresponding author with a reasonable request. Clinical course and risk factors for mortality of adult inpatients with COVID-19 in Wuhan, China: a retrospective cohort study Clinical characteristics of coronavirus disease 2019 in China Pathophysiology, transmission, diagnosis, and treatment of coronavirus disease 2019 (COVID-19): a review World Health Organization. WHO Coronavirus Disease (COVID-19) Dashboard Critical supply shortages: the need for ventilators and personal protective equipment during the Covid-19 pandemic Wuhan and Hubei COVID-19 mortality analysis reveals the critical role of timely supply of medical resources Estimating the risk of COVID-19 death during the course of the outbreak in Korea Rapid COVID-19 vaccine development Risk factors of critical & mortal COVID-19 cases: a systematic literature review and meta-analysis Predictors of mortality in hospitalized COVID-19 patients: a systematic review and meta-analysis Characteristics of and important lessons from the coronavirus disease 2019 (COVID-19) outbreak in China: summary of a report of 72314 cases from the Chinese Center for disease control and prevention PRESS peer review of electronic search strategies: 2015 guideline statement Preferred reporting items for systematic reviews and meta-analyses: the PRISMA statement Meta-analysis of observational studies in epidemiology: a proposal for reporting. Meta-analysis Of Observational Studies in Epidemiology (MOOSE) group Cochrane Handbook for Systematic Reviews of Interventions Meta-analysis in clinical trials Evaluation of the quality of prognosis studies in systematic reviews Bias in meta-analysis detected by a simple, graphical test Clinical features, laboratory characteristics, and outcomes of patients hospitalized with coronavirus disease 2019 (COVID-19): early report from the United States Compassionate remdesivir treatment of severe Covid-19 pneumonia in intensive care unit (ICU) and non-ICU patients: clinical outcome and differences in post-treatment hospitalisation status Characterization and clinical course of 1000 patients with coronavirus disease 2019 in New York: retrospective case series Laboratory predictors of death from coronavirus disease 2019 (COVID-19) in the area of Valcamonica Chest X-ray severity index as a predictor of in-hospital mortality in coronavirus disease 2019: a study of 302 patients from Italy Clinical features and outcomes of 105 hospitalized patients with COVID-19 in Seattle Washington Efficacy and safety of tocilizumab in severe COVID-19 patients: a single-centre retrospective cohort study Analysis of myocardial injury in patients with COVID-19 and association between concomitant cardiovascular diseases and severity of COVID-19 Detectable serum severe acute respiratory syndrome coronavirus 2 viral load (RNAemia) is closely correlated with drastically elevated interleukin 6 level in critically Ill patients with coronavirus disease 2019 Well-aerated lung on admitting chest CT to predict adverse outcome in COVID-19 pneumonia COVID-19 in elderly kidney transplant recipients Use of renin-angiotensin-aldosterone system inhibitors and risk of COVID-19 requiring admission to hospital: a case-population study Suspected myocardial injury in patients with COVID-19: evidence from front-line clinical observation in Wuhan Features of 20 133 UK patients in hospital with covid-19 using the ISARIC WHO Clinical Characterisation Protocol: prospective observational cohort study Predictors of mortality for patients with COVID-19 pneumonia caused by SARS-CoV-2: a prospective cohort study COVID-19 with different severities: a multicenter study of clinical features Characteristics and outcomes of coronavirus disease patients under nonsurge conditions 30-day mortality in patients hospitalized with COVID-19 during the first wave of the Italian epidemic: a prospective cohort study COVID-19: clinical course and outcomes of 36 hemodialysis patients in Spain Correlation between clinical classification of COVID-19 and imaging characteristics of MSCT volume scanning of the lungs COVID-19 in persons with haematological cancers Clinical features and outcomes of 98 patients hospitalized with SARS-CoV-2 infection in Daegu, South Korea: a brief descriptive study Clinical features of patients infected with 2019 novel coronavirus in Wuhan Hypoalbuminemia predicts the outcome of COVID-19 independent of age and co-morbidity Chronological changes of viral shedding in adult inpatients with COVID-19 in Wuhan, China COVID-19: symptoms, course of illness and use of clinical scoring systems for the first 42 patients admitted to a Norwegian local hospital Characteristics of patients with COVID-19 pneumonia at Hvidovre Hospital Clinical and laboratory findings from patients with COVID-19 pneumonia in Babol North of Iran: a retrospective cohort study Characteristics of disease progress in patients with coronavirus disease 2019 in Wuhan Association of obesity with disease severity among patients with coronavirus disease Severe obesity as an independent risk factor for COVID-19 mortality in hospitalized patients younger than 50 Early experience of an infectious and tropical diseases unit during the coronavirus disease (COVID-19) pandemic COVID-19 mortality in patients with cancer on chemotherapy or other anticancer treatments: a prospective cohort study Plasma albumin levels predict risk for nonsurvivors in critically ill patients with COVID-19 Association of renin-angiotensin system inhibitors with severity or risk of death in patients with hypertension hospitalized for coronavirus disease 2019 (COVID-19) infection in Wuhan Association of clinical and radiographic findings with the outcomes of 93 patients with COVID-19 in Wuhan Prognostic value of C-reactive protein in patients with COVID-19 Clinical characteristics and co-infections of 354 hospitalized patients with COVID-19 in Wuhan Clinical characteristics and short-term outcomes of patients with coronavirus disease 2019: a retrospective single-center experience of a designated hospital in Poland Evaluation of hepatic enzymes changes and association with prognosis in COVID-19 patients Factors associated with death outcome in patients with severe coronavirus disease-19 (COVID-19): a case-control study Clinical characteristics of COVID-19 patients With digestive symptoms in Hubei, China: a descriptive, crosssectional, multicenter study Renal involvement and early prognosis in patients with COVID-19 pneumonia Clinical characteristics and outcomes of 112 cardiovascular disease patients infected by 2019-nCoV COVID-19 in solid organ transplant recipients: initial report from the US epicenter Factors associated with hospital admission and critical illness among 5279 people with coronavirus disease Serum hydrogen sulfide and outcome association in pneumonia by the SARS-CoV-2 coronavirus Covid-19 transmission, outcome and associated risk factors in cancer patients at the first month of the pandemic in a Spanish hospital in Madrid Clinical impact of pre-admission antithrombotic therapy in hospitalized patients with COVID-19: a multicenter observational study Novel coronavirus disease 2019: predicting prognosis with a computed tomography-based disease severity score and clinical laboratory data Clinical characteristics and risk factors for mortality of COVID-19 patients with diabetes in Wuhan, China: a twocenter, retrospective study Characteristics and clinical significance of myocardial injury in patients with severe coronavirus disease 2019 Angiopoietin-2 as a marker of endothelial activation is a good predictor factor for intensive care unit admission of COVID-19 patients Coronavirus disease-2019 in cancer patients. A report of the first 25 cancer patients in a western country (Italy) Clinical characteristics and morbidity associated with coronavirus disease 2019 in a series of patients in metropolitan detroit Risk factors for mortality in 244 older adults with COVID-19 in Wuhan, China: a retrospective study Abnormalities of peripheral blood system in patients with COVID-19 in Wenzhou Letter to the Editor: variability but not admission or trends in NEWS2 score predicts clinical outcome in elderly hospitalised patients with COVID-19 An epidemiological study of laboratory confirmed COVID-19 cases admitted in a tertiary care hospital of Pune, Maharashtra Anticoagulant treatment is associated with decreased mortality in severe coronavirus disease 2019 patients with coagulopathy Selective CD8 cell reduction by SARS-CoV-2 is associated with a worse prognosis and systemic inflammation in COVID-19 patients Presentation and outcomes of patients with ESKD and COVID-19 Clinical characteristics of 138 hospitalized patients with 2019 novel coronavirus-infected pneumonia in Wuhan, China Clinical course and outcome of 107 patients infected with the novel coronavirus, SARS-CoV-2, discharged from two hospitals in Wuhan Clinical characteristics of 28 patients with diabetes and Covid-19 in Wuhan Clinical and laboratory predictors of in-hospital mortality in patients with COVID-19: a cohort study in Wuhan, China Epidemiological and clinical features of 125 hospitalized patients with COVID-19 in Fuyang Hypolipidemia is associated with the severity of COVID-19 Suppressed T cell-mediated immunity in patients with COVID-19: a clinical retrospective study in Wuhan Neutrophil to lymphocyte ratio as prognostic and predictive factor in patients with coronavirus disease 2019: a retrospective cross-sectional study Epidemiological and clinical features of 200 hospitalized patients with corona virus disease 2019 outside Wuhan, China: a descriptive study A retrospective study of risk factors for severe acute respiratory syndrome coronavirus 2 infections in hospitalized adult patients Association of radiologic findings with mortality of patients infected with 2019 novel coronavirus in Wuhan, China Obesity predisposes to the risk of higher mortality in young COVID-19 patients Analysis of clinical characteristics and laboratory findings of 95 cases of 2019 novel coronavirus pneumonia in Wuhan, China: a retrospective analysis Do underlying cardiovascular diseases have any impact on hospitalised patients with COVID-19? Risk factors for disease severity, unimprovement, and mortality in COVID-19 patients in Wuhan, China Predictive factors for disease progression in hospitalized patients with coronavirus disease 2019 in Wuhan Viral and host factors related to the clinical outcome of COVID-19 Early decrease in blood platelet count is associated with poor prognosis in COVID-19 patients-indications for predictive, preventive, and personalized medical approach Association of cardiovascular disease and 10 other pre-existing comorbidities with COVID-19 mortality: a systematic review and meta-analysis Diabetes mellitus is associated with increased mortality and severity of disease in COVID-19 pneumonia: a systematic review, meta-analysis, and meta-regression Impact of cerebrovascular and cardiovascular diseases on mortality and severity of COVID-19-systematic review, meta-analysis, and meta-regression Predictive symptoms and comorbidities for severe COVID-19 and intensive care unit admission: a systematic review and meta-analysis Risk factors of severe cases with COVID-19: a meta-analysis Association between male sex and outcomes of Coronavirus Disease 2019 (Covid-19): a Danish nationwide, register-based study Coronavirus COV-19/SARS-CoV-2 affects women less than men: clinical response to viral infection Sex Hormones regulate innate immune cells and promote sex differences in respiratory virus infection Defining community acquired pneumonia severity on presentation to hospital: an international derivation and validation study A prediction rule to identify low-risk patients with community-acquired pneumonia Risk factors for severe outcomes following 2009 influenza A (H1N1) infection: a global pooled analysis Clinical characteristics of coronavirus disease 2019 (COVID-19) in China: a systematic review and meta-analysis Do chronic respiratory diseases or their treatment affect the risk of SARS-CoV-2 infection? Dexamethasone in Hospitalized Patients with Covid-19 Alcoholic liver disease in Asia Per capita alcohol consumption and liver cirrhosis mortality in 14 European countries Alcohol use disorders and community-acquired pneumococcal pneumonia: associated mortality, prolonged hospital stay and increased hospital spending Chronic alcohol consumption increases the severity of murine influenza virus infections National, regional, and global trends in body-mass index since 1980: systematic analysis of health examination surveys and epidemiological studies with 960 country-years and 9ยท 1 million participants Race/ethnicity, underlying medical conditions, homelessness, and hospitalization status of adult patients with COVID-19 at an Urban Safety-Net Medical Center Association of race and ethnicity with comorbidities and survival among patients with COVID-19 at an Urban Medical Center Patterns of COVID-19 testing and mortality by race and ethnicity among United States veterans: a nationwide cohort study Association between ethnicity and severe COVID-19 disease: a systematic review and meta-analysis Potential effects of coronaviruses on the cardiovascular system: a review A review of cardiac manifestations and predictors of outcome in patients with COVID-19 Cancer associates with risk and severe events of COVID-19: a systematic review and meta-analysis Incidence, risk factors, and prognosis of abnormal liver biochemical tests in COVID-19 patients: a systematic review and meta-analysis Coronavirus disease (COVID-19) and the liver: a comprehensive systematic review and meta-analysis COVID-2019 and pregnancy: a plea for transparent reporting of all cases This study was not funded from any other organization. The authors declare no competing interests. The online version contains supplementary material available at https:// doi. org/ 10. 1038/ s41598-021-89182-8.Correspondence and requests for materials should be addressed to J.L. Publisher's note Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations. License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. The images or other third party material in this article are included in the article's Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article's Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit http:// creat iveco mmons. org/ licen ses/ by/4. 0/.